Rchr
J-GLOBAL ID:201601013547898719   Update date: Jun. 11, 2026

Shimizu Takatsune

シミズ タカツネ | Shimizu Takatsune
Affiliation and department:
Other affiliations (1):
Homepage URL  (1): http://www.hoshi.ac.jp/site/kyoiku/KyoinJiseki2015/t-shimizu2.pdf
Research field  (2): Tumor biology ,  Experimental pathology
Research keywords  (8): 腫瘍 ,  癌 ,  環境 ,  drug resistance ,  autophagy ,  微小環境 ,  osteosarcoma ,  dormancy
Research theme for competitive and other funds  (12):
  • 2024 - 2027 骨肉腫の細胞傷害性T細胞疲弊化の分子機構解明と活性化治療法の開発
  • 2021 - 2024 骨肉腫の腫瘍免疫誘導制御に関わる分子機構解明と新規がん免疫療法の開発
  • 2018 - 2020 骨肉腫の疾患特異的代謝の解明と新規治療法開発
  • 2018 - 2019 ドラッグスクリーニングと生体内分子発現解析の融合による希少悪性腫瘍(骨肉腫)の転移を標的とした新規薬物療法開発
  • 2015 - 2018 Investigation of the molecular mechanisms underlying therapeutic resistance in osteosarcoma metastasis
Show all
Papers (49):
  • Ayaka Kunishima, Takatsune Shimizu, Tetsuya Takimoto, Atsunobu Sagara, Hiroyuki Nobusue, Hidetoshi Hasuwa, Shinya Hasegawa, Yuka Tamaoki, Hitomi Miyake, Yumi Fukuchi, et al. Depleting HIF-1α attenuates the progression of osteosarcoma, but tumorigenicity is sustained through HIF-independent pathways. Oncology reports. 2026. 55. 5
  • Atsunobu Sagara, Tomofumi Watanabe, Tomoya Abe, Takatsune Shimizu, Shunsuke Shirozu, Hiroyuki Terakado. Association of family pharmacist continuity with patient-reported satisfaction in patients with metastatic cancer: a nationwide cross-sectional study. Journal of Pharmaceutical Health Care and Sciences. 2026
  • Akihito Nagahama, Atsunobu Sagara, Hayato Aki, Hiroki Yoshimura, Makoto Hiraide, Takatsune Shimizu, Motohiko Sano, Tetsuro Yumoto, Tomoo Hosoe, Kenji Tanaka. Effects of second generation antihistamines on daily driving with and without subtasks measured in a driving simulator. Discover Applied Sciences. 2025. 8. 2
  • Hitoshi Makabe, Yusuke Hamada, Michiko Narita, Kenichi Tanaka, Jion Takise, Risako Tatezuki, Nao Kawamura, Yukari Suda, Takatsune Shimizu, Naoko Kuzumaki, et al. Usefulness of zoledronic acid for the aggravated bone cancer and bone cancer pain. PAIN RESEARCH. 2025. 40. 1. 43-53
  • Jun Saito, Nobuyuki Onishi, Juntaro Yamasaki, Naoyoshi Koike, Yukie Hata, Kiyomi Kimura, Yuji Otsuki, Hiroyuki Nobusue, Oltea Sampetrean, Takatsune Shimizu, et al. Benzaldehyde suppresses epithelial-mesenchymal plasticity and overcomes treatment resistance in cancer by targeting the interaction of 14-3-3ζ with H3S28ph. British journal of cancer. 2025
more...
MISC (38):
  • 清水孝恒, 市川紗衣, 市川穂菜美, 福地由美, 武藤章弘. Nintedanib, an anti-fibrosis agent, suppresses osteosarcoma metastatic progression. 日本薬学会年会要旨集(Web). 2024. 144th
  • 國島綾花, 清水孝恒, 信末博行, 佐谷秀行, 福地由美, 武藤章弘. The critical roles of HIF-1α on in vivo tumorigenesis in osteosarcoma. 日本癌学会学術総会抄録集(Web). 2024. 83rd
  • 福地由美, 國島綾花, 清水孝恒, 武藤章弘. The Potential of Graves’ Disease Mouse Model as a Model for Immune Checkpoint Inhibitor-Induced Thyroiditis. 日本癌学会学術総会抄録集(Web). 2024. 83rd
  • 清水孝恒, 木村聖美, 木村聖美, 杉原英志, 杉原英志, 信末博行, 武藤章弘, 佐谷秀行. 骨肉腫腫瘍免疫の解析,新規免疫療法開発のためのマウスモデル基盤形成. 日本癌学会学術総会抄録集(Web). 2021. 80th
  • 齋藤潤, 齋藤潤, 大西伸幸, 杉原英志, 清水孝恒, 清水孝恒, 木村聖美, 小池直義, 小池直義, サンペトラ オルテア, et al. Benzaldehydeは癌細胞のAxl受容体の発現を14-3-3ζを介して抑制し,Osimertinibによる治療抵抗性を制する. 日本癌学会学術総会抄録集(Web). 2021. 80th
more...
Education (3):
  • 2001 - 2005 Keio University School of Medicine Graduate School of Medicine
  • 1999 - 2001 Keio University School of Medicine Department of Internal Medicine
  • 1993 - 1999 Keio University School of Medicine
Professional career (1):
  • 医学博士 (慶應義塾大学)
Work history (5):
  • 2012/06 - 現在 Keio University School of Medicine Division of Gene Regulation, Institute of Advanced Medical Research Visiting Associate Professor
  • 2012/06 - 現在 Hoshi University Hoshi University
  • 2007/02 - 2012/05 Keio University School of Medicine Division of Gene Regulation, Institute of Advanced Medical Research Assistant Professor
  • 2005/05 - 2007/01 Kumamoto University Graduate School of Medical Sciences, Department of Tumor Genetics and Biology, Postdoctral Fellow
  • 2005/04 - 2006/12 Keio University School of Medicine
Committee career (2):
  • 2020/04 - 現在 The Japanese Society for Clinical Molecular Morphology Councilor
  • 2015/01 - 現在 Japanese Cancer Association Councilor
Awards (1):
  • 2018/09 - Japanese Society for Clinical Molecular Morphology Excellent Presentation Award
Association Membership(s) (7):
日本薬学会 ,  American Association of Cancer Research ,  THE JAPANESE CANCER ASSOCIATION ,  THE JAPANESE SOCIETY OF INTERNAL MEDICINE ,  Meguro Medical Association ,  東京内科医会 ,  日本臨床分子形態学会
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page